×
0 0 0 0 0 0 0 0
Stockreport

Biotech Analysis Central Pharma News: Johnson & Johnson's Partnership, Dynavax's Advancements, Aveo's Positive Results [Seeking Alpha]

Johnson & Johnson (JNJ)  More Company Research Source: Seeking Alpha
Last johnson & johnson earnings: 10/16 06:40 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Summary Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Johnson & Johnson Acquires Rights To A Drug That Treats Rare Forms Of Cancer News: Recently, Johnson & Johnson ( JNJ ) announced that it had created a partnership deal with a Korean biotech named Yuhan ( OTCPK:YUHNF ) . The reason for creating this deal is so that JNJ could get its hands on Yuhan's 3rd generation EGFR tyrosine-kinase inhibitor known as lazertinib. In order to obtain such a deal, JNJ only had to pay an upfront payment of $50 million to Yuhan. If clinical trials proceed accordingly, then Yuhan could also receive up to $1.205 billion in potential milestone payments as well. JNJ will also have to give the biotech tiered double-digit royalty payments for net sales made on any products sold. Analysis: I think this is a good deal for JNJ for a few reasons. The first reason is that it gets to work on the dru [Read more]

IMPACT SNAPSHOT EVENT TIME: JNJ
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
JNJ alerts
from News Quantified
Opt-in for
JNJ alerts

from News Quantified
Opt-in for
JNJ alerts

from News Quantified